Fulgent Genetics, Inc.
FLGT
$19.45
-$0.45-2.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -84.38M | -73.81M | -60.51M | -42.98M | -51.02M |
| Total Depreciation and Amortization | 25.83M | 24.20M | 24.12M | 24.20M | 24.09M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 43.06M | 50.58M | 52.39M | 50.04M | 59.72M |
| Change in Net Operating Assets | -68.20M | -91.08M | -117.63M | -29.74M | -57.87M |
| Cash from Operations | -83.70M | -90.11M | -101.64M | 1.52M | -25.09M |
| Capital Expenditure | -20.09M | -23.06M | -22.57M | -21.37M | -34.86M |
| Sale of Property, Plant, and Equipment | 11.00K | 11.00K | 5.00K | 5.00K | 40.00K |
| Cash Acquisitions | -51.79M | -51.79M | 3.78M | 3.78M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 163.85M | 169.42M | 130.17M | 90.35M | 97.48M |
| Cash from Investing | 91.98M | 94.58M | 111.37M | 72.76M | 62.66M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -828.00K | -828.00K | -870.00K | -918.00K | -966.00K |
| Issuance of Common Stock | 12.00K | 10.00K | 1.00K | 51.00K | 51.00K |
| Repurchase of Common Stock | -69.22M | -47.63M | -13.92M | -13.72M | -13.79M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -70.04M | -48.45M | -14.79M | -14.58M | -14.70M |
| Foreign Exchange rate Adjustments | 181.00K | 97.00K | 105.00K | -104.00K | 38.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -61.58M | -43.88M | -4.95M | 59.60M | 22.90M |